Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity
Source
Cancer drug resistance - ISSN 2578-532X-6:4 (2023) p. 709-728
Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer
Source
Oncoimmunology - ISSN 2162-402X-12:1 (2023) p. 1-11
Auranofin synergizes with the PARP inhibitor olaparib to induce ROS-mediated cell death in mutant p53 cancers
Source
Antioxidants - ISSN 2076-3921-12:3 (2023) p. 1-24
Optimization of the solvent and in vivo administration route of auranofin in a syngeneic non-small cell lung cancer and glioblastoma mouse model
Source
Pharmaceutics - ISSN 1999-4923-14:12 (2022) p. 1-18
Auranofin and cold atmospheric plasma synergize to trigger distinct cell death mechanisms and immunogenic responses in glioblastoma
Source
Cells - ISSN 2073-4409-10:11 (2021) p. 1-22